drugset / Trial / NCT02365857

Intrathecal Dexmedetomidine With Bupivacaine for Spinal Anesthesia in Cesarean Section

NCT02365857 ↗

Phase 4 Completed 120 enrolled Cairo University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A Randomized, Controlled, Double blind study aiming to evaluate the analgesic potentials and side effect profile of different dose levels of Dexmedetomidine added to subarachnoid bupivacaine in full-term pregnant women undergoing elective cesarean section using spinal anesthesia. The investigators ultimate goal is to find out the least effective dose which will be associated with minimal or no side effects. The primary outcome will be the time to two sensory block segment regression.

Timeline

Start
2014-12
Primary completion
2015-07
Completion
2015-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 5 ug Intrathecal
Comparator Dexmedetomidine Other / unclassified 10 ug Intrathecal
Comparator Dexmedetomidine Other / unclassified 15 ug Intrathecal
Comparator Bupivacaine Other / unclassified 12.5 mg Intrathecal

Indications

No indication recorded.